Hsi‐Feng Tu

2.3k total citations
76 papers, 1.8k citations indexed

About

Hsi‐Feng Tu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hsi‐Feng Tu has authored 76 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 34 papers in Cancer Research and 18 papers in Oncology. Recurrent topics in Hsi‐Feng Tu's work include MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (21 papers) and Circular RNAs in diseases (15 papers). Hsi‐Feng Tu is often cited by papers focused on MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (21 papers) and Circular RNAs in diseases (15 papers). Hsi‐Feng Tu collaborates with scholars based in Taiwan, China and United States. Hsi‐Feng Tu's co-authors include Kuo‐Wei Chang, Chung‐Ji Liu, Shu‐Chun Lin, Shou‐Yen Kao, Cheng‐Chieh Yang, K‐W Chang, S‐C Lin, Cheng‐Hsien Wu, Hui-Wen Cheng and Pei-Shih Hung and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Hsi‐Feng Tu

73 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsi‐Feng Tu Taiwan 24 1.2k 1.1k 295 160 154 76 1.8k
Coro Bescós Spain 12 785 0.7× 847 0.8× 343 1.2× 93 0.6× 197 1.3× 35 1.6k
Christina Springstead Scanlon United States 12 511 0.4× 211 0.2× 294 1.0× 46 0.3× 96 0.6× 16 920
Shigehiro Ono Japan 21 593 0.5× 150 0.1× 305 1.0× 66 0.4× 182 1.2× 88 1.2k
Eri Sasabe Japan 18 614 0.5× 450 0.4× 234 0.8× 49 0.3× 92 0.6× 40 1.2k
Steeve Kwan Tat Canada 16 742 0.6× 173 0.2× 477 1.6× 56 0.3× 180 1.2× 18 1.5k
Fengcai Wei China 16 407 0.4× 176 0.2× 217 0.7× 30 0.2× 107 0.7× 52 784
Elena Padín-Iruegas Spain 12 832 0.7× 135 0.1× 111 0.4× 25 0.2× 666 4.3× 35 1.4k
Xicai Sun China 23 410 0.4× 139 0.1× 270 0.9× 11 0.1× 775 5.0× 127 1.6k
Kadir Demircan Türkiye 17 463 0.4× 295 0.3× 165 0.6× 12 0.1× 112 0.7× 53 1.0k
Katarzyna A. Podyma‐Inoue Japan 16 411 0.4× 109 0.1× 154 0.5× 47 0.3× 47 0.3× 38 747

Countries citing papers authored by Hsi‐Feng Tu

Since Specialization
Citations

This map shows the geographic impact of Hsi‐Feng Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsi‐Feng Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsi‐Feng Tu more than expected).

Fields of papers citing papers by Hsi‐Feng Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsi‐Feng Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsi‐Feng Tu. The network helps show where Hsi‐Feng Tu may publish in the future.

Co-authorship network of co-authors of Hsi‐Feng Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Hsi‐Feng Tu. A scholar is included among the top collaborators of Hsi‐Feng Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsi‐Feng Tu. Hsi‐Feng Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Cheng‐Chieh, Jumpei Washio, Yu‐Cheng Lin, et al.. (2025). Microbiome Signatures and Dysbiotic Patterns in Oral Cancer and Precancerous Lesions. Oral Diseases. 31(8). 2456–2465. 1 indexed citations
2.
Zhang, Zhen, et al.. (2025). Global burden of disease changes related to high red meat diets and breast cancer from 1990 to 2021 and its prediction up to 2030. Frontiers in Nutrition. 12. 1586299–1586299. 1 indexed citations
3.
Chang, Kuo‐Wei, et al.. (2023). Cold Atmospheric Plasma Jet Irradiation Decreases the Survival and the Expression of Oncogenic miRNAs of Oral Carcinoma Cells. International Journal of Molecular Sciences. 24(23). 16662–16662. 2 indexed citations
4.
Liu, Chung‐Ji, et al.. (2023). The Concordant Disruption of B7/CD28 Immune Regulators Predicts the Prognosis of Oral Carcinomas. International Journal of Molecular Sciences. 24(6). 5931–5931. 9 indexed citations
5.
Chang, Kuo‐Wei, et al.. (2021). LncRNA MIR31HG Drives Oncogenicity by Inhibiting the Limb-Bud and Heart Development Gene (LBH) during Oral Carcinoma. International Journal of Molecular Sciences. 22(16). 8383–8383. 9 indexed citations
6.
Tu, Hsi‐Feng, et al.. (2021). Co-upregulation of miR-31 and its host gene lncRNA MIR31HG in oral squamous cell carcinoma. Journal of Dental Sciences. 17(2). 696–706. 10 indexed citations
7.
Lin, Shu‐Chun, et al.. (2021). The upregulation of oncogenic miRNAs in swabbed samples obtained from oral premalignant and malignant lesions. Clinical Oral Investigations. 26(2). 1343–1351. 6 indexed citations
8.
Chang, Kuo‐Wei, et al.. (2020). Establishment of a p53 Null Murine Oral Carcinoma Cell Line and the Identification of Genetic Alterations Associated with This Carcinoma. International Journal of Molecular Sciences. 21(24). 9354–9354. 9 indexed citations
9.
Tu, Hsi‐Feng, Michael Yuan‐Chien Chen, Yi‐Ling Chen, et al.. (2019). Arecoline‐regulated ataxia telangiectasia mutated expression level in oral cancer progression. Head & Neck. 41(8). 2525–2537. 23 indexed citations
10.
Tu, Hsi‐Feng, et al.. (2018). miR‐134 targets PDCD7 to reduce E‐cadherin expression and enhance oral cancer progression. International Journal of Cancer. 143(11). 2892–2904. 50 indexed citations
11.
Wu, Yi‐Long, Qi Zhou, Hsi‐Feng Tu, et al.. (2018). P1.01-97 Cluster Trial: Ph2 Biomarker-Integrated Study of Single Agent Alpelisib, Capmatinib, Ceritinib and Binimetinib in advNSCLC. Journal of Thoracic Oncology. 13(10). S500–S501. 1 indexed citations
12.
Wu, Yi‐Long, Qing Zhou, Hsi‐Feng Tu, et al.. (2018). JCSE01.09 Cluster Trial: Ph2 Biomarker-Integrated Study of Single Agent Alpelisib, Capmatinib, Ceritinib and Binimetinib in advNSCLC. Journal of Thoracic Oncology. 13(10). S311–S312. 3 indexed citations
13.
Lyu, Jiao, et al.. (2017). Evaluation of stress and well-being of oral and maxillofacial surgery residents. International Journal of Oral and Maxillofacial Surgery. 46. 370–371. 1 indexed citations
14.
Hung, Kai-Feng, et al.. (2015). MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder. Oral Oncology. 53. 42–47. 69 indexed citations
15.
Hung, Pei-Shih, Hsi‐Feng Tu, Shou‐Yen Kao, et al.. (2014). miR-31 is upregulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes. Carcinogenesis. 35(5). 1162–1171. 66 indexed citations
16.
Tu, Hsi‐Feng, Shu‐Chun Lin, & Kuo‐Wei Chang. (2013). MicroRNA aberrances in head and neck cancer. Current Opinion in Otolaryngology & Head & Neck Surgery. 21(2). 104–111. 69 indexed citations
17.
Tu, Hsi‐Feng, et al.. (2010). Serum decoy receptor 3 level: A predictive marker for nodal metastasis and survival among oral cavity cancer patients. Head & Neck. 33(3). 396–402. 17 indexed citations
18.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Coro Bescós Breakdown of academic impact, for papers by Christina Springstead Scanlon Breakdown of academic impact, for papers by Shigehiro Ono Breakdown of academic impact, for papers by Eri Sasabe Breakdown of academic impact, for papers by Steeve Kwan Tat Breakdown of academic impact, for papers by Fengcai Wei Breakdown of academic impact, for papers by Elena Padín-Iruegas Breakdown of academic impact, for papers by Xicai Sun Breakdown of academic impact, for papers by Kadir Demircan Breakdown of academic impact, for papers by Katarzyna A. Podyma‐Inoue
Rankless by CCL
2026